Abstract
Tenofovir has shown efficacy as first-line therapy for treatment-naive patients with chronic hepatitis B virus (HBV) infection (JW Gastroenterol Jan 23 2009). To evaluate whether tenofovir is effective in treatment-experienced patients — those who failed to respond to nucleoside/nucleotide analogues (NAs) — European investigators conducted a multicenter, retrospective cohort study involving 131 HBV-monoinfected patients who failed …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
